Emotion suppression and mortality risk over a 12-year follow-up

Journal of Psychosomatic Research

Volumn 75, Issue 4, 2013, Pages 381-385

  Chapman, Benjamin P ^a   Fiscella, Kevin ^a   Kawachi, Ichiro ^b   Duberstein, Paul ^a   Muennig, Peter ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Department of Community and Preventive Medicine ^*  (United States)

Author keywords

All cause mortality; Cancer mortality; Cardiovascular disease mortality; Emotion; General Social Survey; Suppression

Indexed keywords

ADULT; ANGER; ARTICLE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; EMOTION; FOLLOW UP; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PROSPECTIVE STUDY; SCORING SYSTEM;

ALL-CAUSE MORTALITY; CANCER MORTALITY; CARDIOVASCULAR DISEASE MORTALITY; EMOTION; GENERAL SOCIAL SURVEY; SUPPRESSION;

AGED; CARDIOVASCULAR DISEASES; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRESSION, PSYCHOLOGY; RISK;

EID: 84885386779     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.07.014     Document Type: Article

References (75)

1. Vaillant G Ego mechanisms of defense: a guide for clinicians and researchers 1992, American Psychiatric Press, Washington, DC.
2. Duberstein PR, Masling JM Psychodynamic perspectives on sickness and health 2000, 363.
3. Mund M, Mitte K The costs of repression: a meta-analysis on the relation between repressive coping and somatic diseases. Health Psychol 2011, 10.1037/a0026257.
4. Giese-Davis J, Spiegel D Suppression, repressive-defensiveness, restraint, and distress in metastatic breast cancer: separable or inseparable constructs?. J Pers 2001, 69:417-449.
5. Myers LB, Vetere A, Derakshan N Are suppression and repressive coping related?. Personal Individ Differ 2004, 36:1009-1013.
6. Consedine NS, Magai C, Bonanno GA Moderators of the emotion-inhibition-health relationship: a review and research agenda. Rev Gen Psychol 2002, 6:204-228.
7. Cramer P Stress, autonomic nervous system reactivity, and defense mechanisms. Defense Mechanisms: Theoretical, Research, and Clinical Perspectives 2004, 325-350. Elsevier. U. Hentschel, G. Smith, J.G. Dragus, W. Ehlers (Eds.).
8. Giese-Davis J, DiMiceli S, Sephton SE, Spiegel D Emotional expression and diurnal cortisol slope in women with metastatic breast cancer in supportive-expressive group therapy. Biol Psychol 2006, 73:190-198.
9. Giese-Davis JSS, Abercrombie HC, Duran REF, Spiegel D Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer. Health Psychol 2004, 23:645-650.
10. Hentschel U, Smith G, Draguns JG Defense mechanisms and their psychophysiological correlates. Defense mechanisms: theoretical, research, and clinical perspectives 2004, Elsevier, Amsterdam.
11. Repression and dissociation: implications for personality theory, psychopathology, and health 1995, University of Chicago Press, Chicago, IL. J.L. Singer (Ed.).
12. Korte SM, Koolhaas JM, Wingfield JC, McEwen BS The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev 2005, 29:3-38.
13. Grossarth-Maticek R, Bastiaans J, Kanazir DT Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: the Yugoslav prospective study. J Psychosom Res 1985, 29:167-176.
14. Grossarth-Maticek R Psychosocial predictors of cancer and internal diseases. An overview. Psychother Psychosom 1980, 33:122-128.
15. Vetter H Some observations on Grossarth-Maticek's data base. Psychol Inq 1991, 2:286-287.
16. Van der Ploeg HM What a wonderful world it would be: a reanalysis of some of the work of Grossarth-Maticek. Psychol Inq 1991, 2:280-285.
17. Temoshok L Assessing the assessment of psychosocial factors. Psychol Inq 1991, 2:276-280.
18. Spiegel D Second thoughts on personality, stress, and disease. Psychol Inq 1991, 2:266-268.
19. Schuler G, Fox BH Questions about Grossarth-Maticek's procedures and results. Psychol Inq 1991, 2:257-261.
20. Lee P Personality and disease: a call for replication. Psychol Inq 1991, 2:251-253.
21. Fox BH Quandaries created by unlikely numbers in some of Grossarth-Maticek's studies. Psychol Inq 1991, 2:242-247.
22. Derogatis LR Personality, stress, disease, and bias in epidemiologic research. Psychol Inq 1991, 2:238-242.
23. Amelang M Tales from Crvenka and Heidelberg: what about the empirical basis?. Psychol Inq 1991, 2:233-236.
24. Coyne JC, Stefanek M, Palmer SC Psychotherapy and survival in cancer: the conflict between hope and evidence. Psychol Bull 2007, 133:367.
25. Eysenck HJ Reply to criticisms of the Grossarth-Maticek studies. Psychol Inq 1991, 2:297-323.
26. Fox BH, Temoshok L, Dreher H Mind-body and behavior in cancer incidence. Advances 1988, 5:41-46.
27. Butow PN, Hiller JE, Price MA, Thackway SV, Kricker A, Tennant CC Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J Psychosom Res 2000, 49:169-181.
28. McKenna MC, Zevon MA, Corn B, Rounds J Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 1999, 18:520-531.
29. Mols F, Denollet J Type D personality among noncardiovascular patient populations: a systematic review. Gen Hosp Psychiatry 2010, 32:66-72. 10.1016/j.genhosppsych.2009.09.010.
30. Harburg E, Julius M, Kaciroti N, Gleiberman L, Schork MA Expressive/suppressive anger-coping responses, gender, and types of mortality: a 17-year follow-up (Tecumseh, Michigan, 1971-1988). Psychosom Med 2003, 65:588-597.
31. Denollet J, Gidron Y, Vrints CJ, Conraads VM Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease. Am J Cardiol 2010, 105:1555-1560. [S0002-9149(10)00101-3 [pii]]. 10.1016/j.amjcard.2010.01.015.
32. Sturmer T, Hasselbach P, Amelang M Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort. Br Med J 2006, 332:1359.
33. Terada K, Kawakami N, Inaba S, Takatsuka N, Shimizu H Rationality/antiemotionality personality and selected chronic diseases in a community population in Japan. J Psychosom Res 2000, 48:31-35.
34. Hirokawa K, Nagata C, Takatsuka N, Shimizu H The relationships of a rationality/antiemotionality personality scale to mortalities of cancer and cardiovascular disease in a community population in Japan. J Psychosom Res 2004, 56:103-111. [S0022399903000461 [pii]]. 10.1016/S0022-3999(03)00046-1.
35. Boscarino JA, Figley CR The impact of repression, hostility, and post-traumatic stress disorder on all-cause mortality: a prospective 16-year follow-up study. J Nerv Ment Dis 2009, 197:461-466. 10.1097/NMD.0b013e3181a61f3e.
36. Muennig P, Johnson G, Kim J, Smith TW, Rosen Z The general social survey-national death index: an innovative new dataset for the social sciences. BMC Res Notes 2011, 4:385. 10.1186/1756-0500-4-385.
37. Ross CE, Mirowsky J Age and the balance of emotions. Soc Sci Med 2008, 66:2391-2400. 10.1016/j.socscimed.2008.01.048.
38. Anastasi A, Urbina S Psychological testing 1997, Prentice Hall, Englewood Cliffs, NJ. 7th Ed.
39. Mirowsky J, Ross CE Sex differences in distress: real or artifact. Am Sociol Rev 1995, 60:426-449.
40. Ferriss AL Studying and measuring civility: a framework, trends, and scale. Sociol Inq 2002, 72:376-392.
41. Bentler PM Alpha, dimension-free, and model-based internal consistency reliability. Psychometrika 2009, 74:137-143.
42. Hermansen SW, Leitzmann MF, Schatzkin A The impact on National Death Index ascertainment of limiting submissions to Social Security Administration Death Master File matches in epidemiologic studies of mortality. Am J Epidemiol 2009, 169:901-908. [kwn404 [pii]]. 10.1093/aje/kwn404.
43. Rothman KJ, Greenland S, Lash TL Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed.
44. Greenland S Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989, 79:340-349.
45. Maldonado G, Greenland S Simulation study of confounder-selection strategies. Am J Epidemiol 1993, 138:923-936.
46. Piantidosi S Clinical trials: a methodologic perspective 2005, John Wiley & Sons, New York. Second ed.
47. Babyak MA What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004, 66:411-421.
48. Harrell FE Regression modeling strategies 2001, Springer-Verlag, New York.
49. Census USBot Current population reports 1996, [Washington, DC].
50. Center for Disease Control NCfHS Healthy people 2000 review 1995/6 1996, [Washington, DC].
51. Kreitler S Defense mechanisms and physical health. Defense mechanisms 2004, Elsevier, Amsterdam. U. Hentschel, G. Smith, J.G. Draguns, W. Ehlers (Eds.).
52. Spiegel D, Bloom JR, Kraemer HC, Gottheil E Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 2:888-891. 10.1016/S0140-6736(89)91551-1.
53. Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001, 345:1719-1726. 10.1056/NEJMoa011871.
54. van der Ploeg HM, Kleijn WC, Mook J, van Donge M, Pieters AM, Leer JW Rationality and antiemotionality as a risk factor for cancer: concept differentiation. J Psychosom Res 1989, 33:217-225. 10.1016/0022-3999(89)90049-4.
55. Weihs KL, Enright TM, Simmens SJ, Reiss D Negative affectivity, restriction of emotions, and site of metastases predict mortality in recurrent breast cancer. J Psychosom Res 2000, 49:59-68.
56. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999, 354:1331-1336.
57. Watson M, Homewood J, Haviland J, Bliss JM Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer 2005, 41:1710-1714. 10.1016/j.ejca.2005.01.012.
58. Petticrew M, Bell R, Hunter D Influence of psychological coping on survival and recurrence in people with cancer: systematic review. Br Med J 2002, 325:1066-1075. 10.1136/bmj.325.7372.1066.
59. Watson M D-HJ, Haviland J, Bliss J Psychological coping and cancer: study results should not have been dismissed. Br Med J 2003, 326-598.
60. Kissane D, Li Y Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 2008, 112:443-444. [author reply 4]. 10.1002/cncr.23179.
61. Spiegel D, Butler LD, Giese-Davis J, Koopman C, Miller E, DiMiceli S, et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 2007, 110:1130-1138. 10.1002/cncr.22890.
62. Spiegel D Mind matters in cancer survival. JAMA 2011, 305:502-503. 10.1001/jama.2011.69.
63. Giese-Davis J, Koopman C, Butler LD, Classen C, Cordova M, Fobair P, et al. Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. J Consult Clin Psychol 2002, 70:916-925. 10.1037//0022-006X.70.4.916.
64. Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 2001, 58:494-501. 10.1001/archpsyc.58.5.494.
65. Campbell RS, Pennebaker JW The secret life of pronouns: flexibility in writing style and physical health. Psychol Sci 2003, 14:60-65.
66. Rosenberg HJ, Rosenberg SD, Ernstoff MS, Wolford GL, Amdur RJ, Elshamy MR, et al. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 2002, 32:37-53.
67. Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med 2004, 66:272-275.
68. Thoits PA Mechanisms linking social ties and support to physical and mental health. J Health Soc Behav 2011, 52:145-161. 10.1177/0022146510395592.
69. Grandi S, Sirri L, Wise TN, Tossani E, Fava GA Kellner's emotional inhibition scale: a clinimetric approach to alexithymia research. Psychother Psychosom 2011, 80:335-344. 10.1159/000328576.
70. Kauhanen J, Kaplan GA, Cohen RD, Julkunen J, Salonen JT Alexithymia and risk of death in middle-aged men. J Psychosom Res 1996, 41:541-549.
71. Honkalampi K, Lehto SM, Koivumaa-Honkanen H, Hintikka J, Niskanen L, Valkonen-Korhonen M, et al. Alexithymia and tissue inflammation. Psychother Psychosom 2011, 80:359-364. 10.1159/000327583.
72. Muennig P, Sohler N, Mahato B Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES. Prev Med 2007, 45:35-40.
73. GrossarthMaticek R, Eysenck HJ, Vetter H Personality type, smoking habit and their interaction as predictors of cancer and coronary heart disease. Personal Individ Differ 1988, 9:479-495. [Eseer Sene].
74. Chapman BP, Roberts B, Duberstein P Personality and longevity: knowns, unknowns, and implications for public health and personalized medicine. J Aging Res 2011, [2011]. 10.4061/2011/759170.
75. Haan N Coping and defending 1977, Academic Press, New York.